PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.792
https://www.valueinhealthjournal.com/article/S1098-3015(19)33170-5/fulltext
Title :
PCV67 BUDGET IMPACT OF RIVAROXABAN 2.5MG IN COMBINATION WITH ASPIRIN IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD) OR PERIPHERAL ARTERY DISEASE (PAD) IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33170-5&doi=10.1016/j.jval.2019.09.792
First page :
Section Title :
Open access? :
No
Section Order :
10691